Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/13301
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJiaranaikulwanitch J.
dc.contributor.authorTadtong S.
dc.contributor.authorGovitrapong P.
dc.contributor.authorFokin V.V.
dc.contributor.authorVajragupta O.
dc.date.accessioned2021-04-05T03:23:09Z-
dc.date.available2021-04-05T03:23:09Z-
dc.date.issued2017
dc.identifier.issn9680896
dc.identifier.other2-s2.0-85009471336
dc.identifier.urihttps://ir.swu.ac.th/jspui/handle/123456789/13301-
dc.identifier.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85009471336&doi=10.1016%2fj.bmc.2016.12.027&partnerID=40&md5=76a77627d1f357759b68ebc7ff292c3a
dc.description.abstractAlzheimer's disease (AD) is a common neurodegenerative disorder, one of the hallmarks of which is the deposition of aggregated β-amyloid peptides (Aβ40,42) as plaques in the brain. Oligomers of these peptides have been reported to be toxic and to inhibit neurite outgrowth, as evidenced by neurite dystrophy and significant loss of synaptic connectivity of neurons in the AD brain resulting in cognitive decline. These peptides also react with biological metal in the brain to generate free radicals, thereby aggravating neuronal cell injury and death. Herein, multifunctional triazole-based compounds acting on multiple targets, namely β-secretase (BACE1), β-amyloid peptides (Aβ) as well as those possessing metal chelation and antioxidant properties, were developed and evaluated for neuritogenic activity in P19-derived neurons. At the non-cytotoxic concentration (1 nM), all multifunctional compounds significantly enhanced neurite outgrowth. New bis-tryptoline triazole (BTT) increased the neurite length and neurite number, by 93.25% and 136.09% over the control, respectively. This finding demonstrates the ability of multifunctional compounds targeting Aβ to enhance neurite outgrowth in addition to their neuroprotective action. © 2016 Elsevier Ltd
dc.subjectamyloid beta protein
dc.subjectbeta secretase
dc.subjectbis tryptoline triazole derivative
dc.subjectgeldanamycin
dc.subjectquercetin
dc.subjecttriazole derivative
dc.subjectunclassified drug
dc.subjectaspartic proteinase
dc.subjectBACE1 protein, human
dc.subjectcarboline derivative
dc.subjectenzyme inhibitor
dc.subjectneuroprotective agent
dc.subjectsecretase
dc.subjecttriazole derivative
dc.subjecttryptoline
dc.subjectantioxidant activity
dc.subjectArticle
dc.subjectchelation
dc.subjectconcentration response
dc.subjectcontrolled study
dc.subjectcytotoxicity
dc.subjectdrug activity
dc.subjectdrug screening
dc.subjectdrug structure
dc.subjectdrug targeting
dc.subjectnerve cell
dc.subjectneurite outgrowth
dc.subjectneuritogenic activity
dc.subjectneuroprotection
dc.subjectanimal
dc.subjectantagonists and inhibitors
dc.subjectcell line
dc.subjectcell survival
dc.subjectchemical structure
dc.subjectchemistry
dc.subjectdose response
dc.subjectdrug effects
dc.subjecthuman
dc.subjectmetabolism
dc.subjectmouse
dc.subjectneurite
dc.subjectstructure activity relation
dc.subjectsynthesis
dc.subjectAmyloid Precursor Protein Secretases
dc.subjectAnimals
dc.subjectAspartic Acid Endopeptidases
dc.subjectCarbolines
dc.subjectCell Line
dc.subjectCell Survival
dc.subjectDose-Response Relationship, Drug
dc.subjectEnzyme Inhibitors
dc.subjectHumans
dc.subjectMice
dc.subjectMolecular Structure
dc.subjectNeurites
dc.subjectNeuroprotective Agents
dc.subjectStructure-Activity Relationship
dc.subjectTriazoles
dc.titleNeuritogenic activity of bi-functional bis-tryptoline triazole
dc.typeArticle
dc.rights.holderScopus
dc.identifier.bibliograpycitationBioorganic and Medicinal Chemistry. Vol 25, No.3 (2017), p.1195-1201
dc.identifier.doi10.1016/j.bmc.2016.12.027
Appears in Collections:Scopus 1983-2021

Files in This Item:
There are no files associated with this item.


Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.